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gene could be a risk genetic marker of T2DM in Han population in
China. In contrast, the CC genotype and C allele of rs2617849 in gp78
gene could be a protective genetic marker of T2DM in Han population
in China.GW26-e4586
Endothelin-1 Upregulates CTRP9 Gene Expression in Cardiomyocytes
Bingyan Guo, Yongjun Li
The Second Hospital of Hebei Medical University
OBJECTIVES C1q / TNF-related protein (CTRP) 9, as an adiponectin
paralog, is an adipocytokine that play an important role in glucose and
lipid metabolism. ET-1 has been shown to induce insulin resistance in
vitro and in vivo and proposed that it might regulate adiponectin
expression. In the present study, we explored the regulatory effects of
ET-1 on CTRP 9 gene expression and the underlying mechanisms in
hypertrophic cardiomyocytes.
METHODS Neonatal rat ventricular myocytes (NRVMs) were treated
with various concentrations of ET-1, and CTRP9 gene expression was
measured by quantitative real-time reverse transcription-polymerase
chain reaction.
RESULTS ET-1 was found to cause a signiﬁcant time- and dose-
dependent increase in CTRP 9 gene expression, and this effect was
inhibited by the ET type A receptor (ETAR) antagonist BQ-610 but
not by the ETBR antagonist BQ-788. To explore the underlying
mechanism, we examined the involvement of the cAMP-dependent
protein kinase A-, phospholipase A2-, protein kinase C-, and MAPK
mediated pathways using inhibitors and found that only PD98059
and U0126, inhibitors that blocked MAPK/ERK kinase’s ability
to activate the ERKs, prevented ET-1-induced up-regulation of
CTRP 9.
CONCLUSIONS These data suggest a mechanism whereby ET-1
upregulates CTRP 9 gene expression in NRVMs via the ET type A re-
ceptor/ MAPK/ERK signaling pathway.GW26-e4778
Constitutive Expression of IGF-1 in BMSCs Improves Migration, Attenuates
Cardiomyocyte Apoptosis and Promotes Cardiac Function After Acute
Myocardial Infarction in Rats.
Jia Xu, Ren Jiang, Hong Zhan, Ruibin Cai, Zi Ye, Yan Xiong
1st afﬁliated hospital of Sun Yat-sen University
OBJECTIVES In this study, we explored the potential role of intra-
myocardial BMSCs-IGF-1 transplanation in reducing cardiomyocyte
apoptosis,mediating cell migration and restoring myocardial function.
METHODS BMSCs were lentivirally transduced to express stable
forms of IGF-1. AMI model was induced by ligation of left main cor-
onary artery in female Sprague-Dawley rats. Experimental rats were
randomized into 3 groups: AMI (group control),BMSCs transplantation
(group M), BMSCs-IGF-1 transplanation (group IGF-1-M). BMSCs and
BMSCs-IGF-1 were injected via cauda vein in recipient rats 3 and 7days
after MI,the EGFP donor cells were traced in MSCs recipient rats by
ﬂuorescence microscopy. VEGF and CXCR4 mRNA and protein
expression in the region bordering an infarct were determined by
means of RT-PCR and western blot analysis. HE staining and TUNEL
were performed to assess pathological changes and cardiomyocyte
apoptosis and proliferation, respectively. LV function was evaluated
using echocardiography.
RESULTS Signiﬁcant improvement of myocardial deﬁcits was found
in BMSCs-IGF-1-transplanted rats compared with control animals at 3
days and 7 days after AMI. Histological evaluation showed that
BMSCs-IGF-1 transplantation signiﬁcantly promoted cardiomyocyte
survival and attenuated neuronal apoptosis in the ischemic boundary
area especially at 7 day. VEGF and CXCR4 were upregulated at mRNA
and protein levels in IGF-1-modiﬁed BMSCs. On the other hand, MI-
dilated impaired LV function with reduced fractional shortening,
cardiomyocyte peak shortening and relengthening were improved by
BMSCs-IGF-1 therapy which were superior to BM-MSCs and control
group at both of 3 and 7 days.
CONCLUSIONS Intra-myocardial delivery of BMSCs-IGF-1 could
selectedly migrate to peri-infarct area, activated transcription genes,
attenuated MI-induced apoptosis, and restored LV function. Taken
together, transplantation of BMSCs-IGF-1 represent a new strategy to
improve cardiac function after MI superior to bone marrow MSCs with
higher security and efﬁciency.GW26-e5322
Downregulation of MicroRNA-17 Improves Cardiac Function After
Myocardial Infarction Via Attenuation of Apoptosis in Endothelial Cells
Shuo Yang, Jing Chen, Qi Hu, Changwu Xu, Hong Jiang
Department of Cardiology, Renmin Hospital of Wuhan University,
Wuhan, China
OBJECTIVES Impairment of microcirculation is one of the major
reasons for the aggravation of cardiac function after myocardial
infarction (MI). Studies have indicated that microRNA - 17 (miR-17) has
the ability to inhibit angiopoiesis in tumors. Here we hypothesized
that downregulation of miR-17 might enhance cardiac function after
MI though improving endothelial function and increasing the density
of new blood vessels after MI.
METHODS Human umbilical vein endothelial cells (HUVECs) were
infected with adenovirus containing pre-mir-17,antagomir-17 or con-
trol adenovirus (Ad(N)) for miR-17 over expression (Ad-Pre-miR-17) or
miR-17 silencing (Ad-Antagomir-17). Apoptosis was induced and
determined by Annexin V-7ADD/PI. Real time RTPCR was used to
evaluate levels of miR-17 and ERK. Protein levels of ERK and
apoptosis proteins including bcl2,bax,caspas3 and caspas9 were
determined by western blot In vivo, MI model was established in SD
male rats. Adenoviruses (5*109/100ml) mentioned above were injec-
ted into the apex of heart. Cadiac function was evaluated by echo-
cardiography before models were built, and reevaluated at 7 days or
28 days after MI. Followed with echocardiography cardiac tissue of
infarction border area was removed for histological examination, real
time RT-PCR and western blot, as described above.
RESULTS MiR-17 level was down regulated by 23% in Ad-Antago-
mir-17 group, but up regulated 2.7-fold in Ad-Pre-miR-17 group
(p <0.05). ERK pathway could be stimulated by miR-17 silencing,
which demonstrated increased levels of phosphorylated ERK(P-
ERK) and anti-apoptosis protein bcl-2 1.42-fold and 1.40-fold.
However, apoptosis proteins, including bax,caspas3, caspas9 were
decreased by 23.1%,29.2%,33%,respectively(p<0.05) in Ad-Antago-
mir-17 group. In Ad-pre-mir-17group,PERK and bcl-2 were down
regulated by 11.4% and 69.8%,while apoptosis proteins mentioned
above were up regulated by 2.05-fold, 1.35-fold, 2.04-fold, respec-
tively (p<0.05) MiR-17 level was decreased by 9.7%and 41.2%,
respectively, in hearts from rats in Ad-Antagomir-17 group after MI
was established for 7 days or 28 days (p<0.05). Echocardiography
revealed that down regulation of miR-17 enhanced the heart ejec-
tion fraction(EF) by 2.18-fold at 7 days, and 2.24-fold at 28 days
(p<0.05). After 7day MI or 28day MI, histological examination
showed that infarction areas and collagen ﬁber were decreased by
43.7% and 73.2%,53.3% and 61.1%,respectively in Ad-Antagomir-17
group (p<0.05). Tunel staining showed that down regulation of
miR-17 could inhibit apoptosis of cardiac tissue compared to Ad(N)
group (0.230.101 vs.0.610.056,0.200.0108 vs.0.410.038,
p<0.05). CD31 staining also indicated that miR-17 silencing
could promote endothelial growth after MI(0.8140.047
vs.0.3600.166,0.7360.069 vs.0.4320.181,p<0.05).
CONCLUSIONS Apoptosis in ECs could be inhibited by down regula-
tion of miR17 though ERK pathway. Down regulation of microRNA17
could improve cardiac function after myocardial infarction via atten-
uation of apoptosis in endothelial cells.GW26-e0112
Curcumin Modulates Macrophage Polarization Through the Inhibition of the
Toll-Like Receptor 4-Mitogen Activated Protein Kinase/Nuclear Factor-kB
Pathways
Yaoyao Zhou, Junfeng Zhang
Department of Cardiology, No. 3 People’s Hospital, Shanghai Jiao Tong
University School of Medicine, Shanghai
OBJECTIVES Curcumin, the active ingredient in curcuma rhizomes,
has a wide range of therapeutic effects. However, its atheroprotective
activity in human acute monocytic leukemia THP-1 cells remains
unclear. We investigated the activity and molecular mechanism of
action of curcumin in polarized macrophages.
METHODS Phorbol myristate acetate (PMA)-treated THP-1 cells were
differentiated to macrophages, which were further polarized to M1
cells by lipopolysaccharide (LPS; 1 mg/ml) and interferon (IFN)-g (20
ng/ml) and treated with varying curcumin concentrations. [3H]
thymidine (3H-TdR) incorporation assays were utilized to measure
curcumin-induced growth inhibition. The expression of tumor ne-
crosis factor-a (TNF-a), interleukin (IL-6), and IL-12 were measured
